09997 KANGJI MEDICAL
Suspend Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 7.92X | Oper Margin | 70.1% |
|---|---|---|---|
| LT Debt/Equity | 0.0% | Net Margin | 57.7% |
| Total Debt/Equity | 0.1% | Return on Equity | 22.1% |
| Price/Book | 3.64X | Return on Assets | 19.9% |
| (HKD 8.420) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 618.36 | 555.53 | 536.76 | 558.70 | 297.05 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +11.3 | +3.5 | -3.9 | +88.1 | +28.7 |
| Earnings Per Share (HKD) | 0.526 | 0.475 | 0.444 | 0.456 | 0.312 |
| Earnings Per Share Growth (%) | +10.8 | +6.9 | -2.6 | +46.3 | +100.0 |
| Dividend Per Share (HKD) | 0.261 | 1.539 | 0.205 | 0.172 | 0.044 |
| P/E* (X) | 16.01 | 17.73 | 18.95 | 18.45 | 27.00 |
| Yield (%) | 3.10 | 18.27 | 2.43 | 2.05 | 0.52 |
| Dividend Share (%) | 49.69 | 324.05 | 46.09 | 37.76 | 14.11 |
| Book NAV (HKD) | 2.313 | 3.306 | 3.102 | 3.201 | 2.783 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,009 | 926.023 | +9.0 | 786.367 |
| Operating Result | 706.694 | 588.723 | +20.0 | 562.953 |
| Associates | -21.861 | 0 | N/A | 0 |
| Profit Before Taxation | 684.833 | 588.771 | +16.3 | 563.144 |
| Taxation | 113.556 | 136.476 | -16.8 | 101.97 |
| Profit /( Loss) After Taxation | 571.277 | 452.295 | +26.3 | 461.174 |
| Minority Interests | -10.161 | -51.726 | -80.4 | -17.561 |
| Net Profit | 581.438 | 504.021 | +15.4 | 478.735 |
| Earnings Per Share () | 0.5259 | 0.4748 | +10.8 | 0.4443 |
| Dividend Per Share () | 0.2613 | 1.5386 | -83.0 | 0.2048 |
| Announcement Date | 2025-03-24 | 2024-03-20 | NA | 2023-03-27 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
